Accufy Diagnostics, Inc. — SEC Form D Filing
Accufy Diagnostics, Inc. filed an SEC Form D on October 28, 2026, reporting $2.00M raised in Biotechnology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- October 28, 2026
- Amount reported
- $2.00M
- Round stage
- Seed, as raising $2,000,000 through an equity offering typically corresponds to early-stage diagnostic development and platform validation.
- Industry
- Biotechnology
- Website
- https://accufydiagnostics.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Clinical laboratories and healthcare providers face delays and inaccuracies when using traditional diagnostic assays to identify complex biological markers.
Solution
Accufy Diagnostics develops high-sensitivity biotechnology diagnostic assays and platforms to streamline accurate disease detection.
Why now
Advancements in molecular biology and rapid microfluidic technology now allow diagnostic tools to achieve higher precision at significantly lower costs.
Source: SEC EDGAR Form D filing